Circulation. 2008;117:711-713
doi: 10.1161/CIRCULATIONAHA.107.188520
(Circulation. 2008;117:711-713.)
© 2008 American Heart Association, Inc.
Clinical Summaries
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Cell Therapy for Modification of the Myocardial Electrophysiological Substrate
|
|---|
Cardiac arrhythmias account for significant worldwide morbidity
and mortality. Preventive antiarrhythmic therapies are aimed
at modifying the abnormal electrophysiological substrate by
either focal injury (surgery or radiofrequency catheter ablation)
or pharmacological therapy. Antiarrhythmic drug therapy has
been hampered by often low efficacy, global cardiac and systemic
actions that often lead to poorly tolerated systemic side effects,
and most important, life-threatening proarrhythmic effects.
In this study, we present a novel combined cell and gene therapy
approach for the modification of the myocardial electrophysiological
substrate. Using fibroblast cell grafts genetically engineered
to express specific potassium ionic channels, we aimed to perform
a targeted modification of local cardiac electrophysiological
properties. Detailed in vitro, in vivo, and computer modeling
studies demonstrated the feasibility of this approach by showing
that the engineered cells could couple with host cardiac cells
and that this modified their electrophysiological properties.
The cell grafts modulated important properties that are of interest
for future antiarrhythmic strategies. These include prolongation
of the local refractory period by a mechanism that does not
involve action potential prolongation (potentially reducing
the proarrhythmic risk associated with many antiarrhythmic agents
that prolong the QT interval) and reduction in local automaticity
(decreasing the spontaneous firing rate). See p 720.
 |
Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression
|
|---|
Vascular thrombi develop in the presence of reduced blood velocities,
when the activity of the clotting system is increased, and in
the presence of endothelial alterations (Virchows triad).
Virchows triad also applies to atrial thrombus formation
during atrial fibrillation (AF). It is well known that AF causes
loss
. . . [Full Text of this Article]
Related Articles:
-
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients
- Alanna Coolong, Donald S. Baim, Richard E. Kuntz, A. James OMalley, Sachin Marulkar, Donald E. Cutlip, Jeffrey J. Popma, and Laura Mauri
Circulation 2008 117: 790-797.
[Abstract]
[Full Text]
-
Cell Therapy for Modification of the Myocardial Electrophysiological Substrate
- Lior Yankelson, Yair Feld, Tal Bressler-Stramer, Ilanit Itzhaki, Irit Huber, Amira Gepstein, Doron Aronson, Shimon Marom, and Lior Gepstein
Circulation 2008 117: 720-731.
[Abstract]
[Full Text]
-
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
- Ralph B. DAgostino, Sr, Ramachandran S. Vasan, Michael J. Pencina, Philip A. Wolf, Mark Cobain, Joseph M. Massaro, and William B. Kannel
Circulation 2008 117: 743-753.
[Abstract]
[Full Text]
-
Oral Buflomedil in the Prevention of Cardiovascular Events in Patients With Peripheral Arterial Obstructive Disease: A Randomized, Placebo-Controlled, 4-Year Study
- Limbs International Medicinal Buflomedil (LIMB) Study Group
Circulation 2008 117: 816-822.
[Abstract]
[Full Text]
-
Dietary Intake and the Development of the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study
- Pamela L. Lutsey, Lyn M. Steffen, and June Stevens
Circulation 2008 117: 754-761.
[Abstract]
[Full Text]
-
Visceral Adipose Tissue Inflammation Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice
- Miina K. Öhman, Yuechun Shen, Chinyere I. Obimba, Andrew P. Wright, Mark Warnock, Daniel A. Lawrence, and Daniel T. Eitzman
Circulation 2008 117: 798-805.
[Abstract]
[Full Text]
-
Technetium 99m–Labeled Annexin V Scintigraphy of Platelet Activation in Vegetations of Experimental Endocarditis
- Francois Rouzet, Miguel Dominguez Hernandez, Florence Hervatin, Laure Sarda-Mantel, Agnes Lefort, Xavier Duval, Liliane Louedec, Bruno Fantin, Dominique Le Guludec, and Jean-Baptiste Michel
Circulation 2008 117: 781-789.
[Abstract]
[Full Text]
-
Identification of Target Domains of the Cardiac Ryanodine Receptor to Correct Channel Disorder in Failing Hearts
- Takeshi Yamamoto, Masafumi Yano, XiaoJuan Xu, Hitoshi Uchinoumi, Hiroki Tateishi, Mamoru Mochizuki, Tetsuro Oda, Shigeki Kobayashi, Noriaki Ikemoto, and Masunori Matsuzaki
Circulation 2008 117: 762-772.
[Abstract]
[Full Text]
-
Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk
- Aruna D. Pradhan, Sanjay Shrivastava, Nancy R. Cook, Nader Rifai, Mark A. Creager, and Paul M Ridker
Circulation 2008 117: 823-831.
[Abstract]
[Full Text]
-
Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages
- V. Bourlier, A. Zakaroff-Girard, A. Miranville, S. De Barros, M. Maumus, C. Sengenes, J. Galitzky, M. Lafontan, F. Karpe, K.N. Frayn, and A. Bouloumié
Circulation 2008 117: 806-815.
[Abstract]
[Full Text]
-
Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression
- Andreas Goette, Alicja Bukowska, Uwe Lendeckel, Michaela Erxleben, Matthias Hammwöhner, Denis Strugala, Jan Pfeiffenberger, Friedrich-Wilhelm Röhl, Christof Huth, Matthias P.A. Ebert, Helmut U. Klein, and Christoph Röcken
Circulation 2008 117: 732-742.
[Abstract]
[Full Text]
-
Adenosine Modulates Cardiovascular Functions Through Activation of Extracellular Signal-Regulated Kinases 1 and 2 and Endothelial Nitric Oxide Synthase in the Nucleus Tractus Solitarii of Rats
- Wen-Yu Ho, Pei-Jung Lu, Michael Hsiao, Hwong-Ru Hwang, Yu-Chou Tseng, Mao-Hsiung Yen, and Ching-Jiunn Tseng
Circulation 2008 117: 773-780.
[Abstract]
[Full Text]